INST MEXICANO DEL SEGURO SOCIAL has a total of 41 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in Mexico. Its main competitors in its focus markets environmental technology are MARUI KAKO KK, LI YUANGANG and KYUSHU MEDICAL KK.
Use of the combination of biomarkers and serum antibodies for the diagnosis of human tuberculosis.
MX2017004323A
Use of an ageratina pichinchensis extract for the treatment of vulvovaginitis caused by candida albicans.
MX2016014325A
Introducer device and positioner for intra-corporeal guides and catheters.
MX2016011500A
Alvaradoa amorphoides extract, method for obtaining the same and its use in the cancer treatment.
MX2016011501A
Serjania goniocarpa extract, method for obtaining the same and its use in the cancer treatment.
MX2016008475A
Use of moussonia deppean extract for the treatment of rheumatoid arthritis.
MX2016007881A
Use of an ageratina pichinchensis extract for the treatment of the minor recurrent aphthous stomatitis.
MX2016007880A
Smart target cane with obstacle evasion.
MX2016002089A
Hydro-alcoholic extract of malva parviflora and its use for preventing and/or treating symptoms associated with chronic-degenerative neurological disorders.
MX2015017677A
Multivalent vaccine containing s.typhi and s.typhimurium porins against tifoidea, paratifoidea, and non-typhoidal salmonellosi.
MX2015005430A
Use of a hexano-ethyl acetate extract of ageratina pichinchensis for the treatment of diabetic foot ulcers.
MX2015003374A
Customized surgical guides.
MX2014015982A
Puncture training device by fluoroscopy.
MX2014007804A
Use of pentapeptide monocyte locomotion inhibitory factor (milf) mqcns as a neuroprotector and immunomodulator in spine cord injuries.
MX2014004998A
Biochip of dna for detecting sequences of human papilloma virus in infected tissue.
MX2014003373A
Pharmaceutical composition comprising extract of sphaeralcea angustifolia for treating osteoarthritis.
MX2013015017A
USE OF 7-O-(ß-D-GLUCOPYRANOSYL)-GALECTIN FOR TREATING AND HEALING SKIN INJURES.
MX2013005302A
Use of dimeric naphthoquinones in the treatment and control of tuberculosis resistant to drugs.
MX2012014853A
Rna synthetic molecules obtained from novel plasma vectors, methods for obtaining the same and use thereof as positive controls in the detection of influenza h1n1.
